FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9342511000001108: Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1672321000001111 Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1672341000001118 Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Is a Ciclesonide 160micrograms/actuation inhaler CFC free 60 dose true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Is pack of Alvesco 160 inhaler (Covis Pharma Europe B.V.) false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has active ingredient Ciclesonide false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has AMP Alvesco 160 inhaler (Covis Pharma Europe B.V.) true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has specific active ingredient Ciclesonide true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start